fbpx

Allergan Acquired by Abbot Labs Spin off, AbbVie Inc.

AbbVie Inc., the pharma spin-off from Abbot Labs and Allergan announced that the companies have entered into a definitive transaction agreement under which AbbVie will acquire Allergan in a cash and stock transaction for a transaction equity value of approximately $63 billion.

According to Allergan, the portfolio including medical aesthetics, eye care, CNS and gastrointestinal businesses, will enhance AbbVie’s growth platform and create substantial value for shareholders of both companies. 

The strategic rationale cited in the news release is that Allergan’s product portfolio will be enhanced by AbbVie’s commercial expertise and international infrastructure. 

Upon completion of the transaction, AbbVie will continue to be incorporated in USA and have its principal executive offices in North Chicago, Illinois and will continue to be led by current chairman and CEO, Richard A. Gonzalez. Two members of Allergan’s Board, including chairman and chief executive officer, Brent Saunders, will join AbbVie’s Board upon completion of the transaction.

Click HERE for the full press release.

Featured Posts

LE PARC: Discover the New Fall/Winter Collection 2023

Inspired by art, culture and creative freedom, LE PARC designs vibrant and sophisticated eyewear that highlights the identity of each individual.

Learn More

Cone-Rod Dystrophy

A new company, Beacon Therapeutics, has launched with a focus on gene therapies for cone-rod dystrophy and X-linked retinitis pigmentosa.

Read more

Students and Binocular Vision: The Hidden Obstacle

Two weeks into the start of the school year, young adults returning to the lecture hall are frantically requesting appointments to the office.

Read more

Myopia Profile Enhances its Managing Myopia Reference Guide to Elevate Patient Care

Free Multi-Part Resource Available for Download in 10 Languages

Read more

Registration Now Open for Vision Expo East 2024

The Vision Council and RX announce that registration for Vision Expo East 2024 is officially open.

Read more

LE PARC: Discover the New Fall/Winter Collection 2023

Inspired by art, culture and creative freedom, LE PARC designs vibrant and sophisticated eyewear that highlights the identity of each individual.

Learn More

Cone-Rod Dystrophy

A new company, Beacon Therapeutics, has launched with a focus on gene therapies for cone-rod dystrophy and X-linked retinitis pigmentosa.

Read More

Students and Binocular Vision: The Hidden Obstacle

Two weeks into the start of the school year, young adults returning to the lecture hall are frantically requesting appointments to the office.

Read More

Myopia Profile Enhances its Managing Myopia Reference Guide to Elevate Patient Care

Free Multi-Part Resource Available for Download in 10 Languages

Read More

Registration Now Open for Vision Expo East 2024

The Vision Council and RX announce that registration for Vision Expo East 2024 is officially open.

Read More

LE PARC: Discover the New Fall/Winter Collection 2023

Inspired by art, culture and creative freedom, LE PARC designs vibrant and sophisticated eyewear that highlights the identity of each individual.

Learn More

Cone-Rod Dystrophy

A new company, Beacon Therapeutics, has launched with a focus on gene therapies for cone-rod dystrophy and X-linked retinitis pigmentosa.

Read more

Students and Binocular Vision: The Hidden Obstacle

Two weeks into the start of the school year, young adults returning to the lecture hall are frantically requesting appointments to the office.

Read more

Myopia Profile Enhances its Managing Myopia Reference Guide to Elevate Patient Care

Free Multi-Part Resource Available for Download in 10 Languages

Read more

Registration Now Open for Vision Expo East 2024

The Vision Council and RX announce that registration for Vision Expo East 2024 is officially open.

Read more

LE PARC: Discover the New Fall/Winter Collection 2023

Inspired by art, culture and creative freedom, LE PARC designs vibrant and sophisticated eyewear that highlights the identity of each individual.

Learn More

Cone-Rod Dystrophy

A new company, Beacon Therapeutics, has launched with a focus on gene therapies for cone-rod dystrophy and X-linked retinitis pigmentosa.

Read more

Students and Binocular Vision: The Hidden Obstacle

Two weeks into the start of the school year, young adults returning to the lecture hall are frantically requesting appointments to the office.

Read more

Myopia Profile Enhances its Managing Myopia Reference Guide to Elevate Patient Care

Free Multi-Part Resource Available for Download in 10 Languages

Read more

Registration Now Open for Vision Expo East 2024

The Vision Council and RX announce that registration for Vision Expo East 2024 is officially open.

Read more